Evicenter
Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer
Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All questions

Real-world evidence: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer

2 questions · 1 source

Real-world evidence

What were TRODELVY real-world survival outcomes in previously treated metastatic TNBC?

What TRODELVY side effects and dose changes were seen in real-world use?